|
[1]
|
Panayiotopoulos, C.P. (2005) The Epilepsies: Seizures, Syndromes and Management: Based on the ILAE Classifications and Practice Parameter Guidelines. Bladon Medical Publishing.
|
|
[2]
|
张军, 谢庆荣, 等. 抗癫痫新药-奥卡西平[J]. 国外医学神经病学神经外科学分册, 1996, 23(1): 38.
|
|
[3]
|
Dogan, E.A., Usta, B.E., Bilgen, R., Senol, Y. and Aktekin, B. (2008) Efficacy, Tolerability, and Side Effects of Oxcarbazepine Monotherapy: A Prospective Study in Adult and Elderly Patients with Newly Diagnosed Partial Epilepsy. Epilepsy & Behavior, 13, 156-161. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
侯国勇, 郑文泉, 赵文燕, 等. 奥卡西平治疗癫痫患者22例临床分析[J]. 中国医药指南, 2011, 9(55): 365-366.
|
|
[5]
|
曾凡明. 奥卡西平治疗癫痫的临床效果观察[J]. 中国医药指南, 2011, 9(1): 16-19.
|
|
[6]
|
何军, 何爱南. 难治性癫痫病30例临床分析[J]. 中国基层医药, 1999, 6(3): 185-186.
|
|
[7]
|
Martinez, W., Ingenito, A., Blakeslee, M., Barkley, G.L., McCague, K. and D’Souza, J. (2006) Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy. Epilepsy & Behavior, 9, 448-456. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
田国红, 赵中新. 左乙拉西坦——一种具有全新作用机制的抗癫痫新药[J]. 中国新药和临床杂志, 2006, 25(10): 782-786.
|
|
[9]
|
Shorvon, S.D., Löwenthal, A., Janz, D., Bielen, E. and Loiseau, P. (2000) Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures. Epilepsia, 41, 1179-1186. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kuba, R., Novotna, I., Brazdil, M., et al. (2010) Long-Term Levetiracetam Treatment in Patients with Epilepsy: 3-Year Follow up. Acta Neurologica Scandinavica, 121, 83-88. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Halma, E., de Louw, A.J.A., Klinkenberg, S., Aldenkamp, A.P., IJff, D.M. and Majoie, M. (2014) Behavioral Side-Effects of Levetiracetam in Children with Epilepsy: A Systematic Review. Seizure, 23, 685-691. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
刘伟, 蔡兴秋. 左乙拉西坦单药或添加治疗癫痫的临床观察[J]. 临床神经病学杂志, 2012, 25(3): 227-230.
|
|
[13]
|
朱军, 叶兴荣, 王爱茹, 陈小华, 顾卫霞, 庄志清. 奥卡西平与左乙拉西坦治疗新诊断部分性发作癫痫患儿的疗效分析[J]. 安徽医学, 2011, 33(11): 1468-1471.
|